Effect of oral therapy with monoisoamyl meso-2,3-dimercaptosuccinate on 203Hg retention in rats
- PMID: 8167441
- DOI: 10.1007/BF00194134
Effect of oral therapy with monoisoamyl meso-2,3-dimercaptosuccinate on 203Hg retention in rats
Similar articles
-
Monoisoamyl meso-2,3-dimercaptosuccinate as a delayed treatment for mercury removal in rats.Environ Health Perspect. 1994 Sep;102 Suppl 3(Suppl 3):309-11. doi: 10.1289/ehp.94102s3309. Environ Health Perspect. 1994. PMID: 7843123 Free PMC article.
-
Superiority of Mi-ADMS to DMSA as parenteral treatment for decreasing mercury (203Hg) body burden in rats.Arh Hig Rada Toksikol. 1993 Sep;44(3):217-22. Arh Hig Rada Toksikol. 1993. PMID: 8311694
-
Monoisoamyl and mono-n-hexyl meso-2,3-dimercaptosuccinate in mobilizing 203Hg retention in relation to age of rats and route of administration.J Appl Toxicol. 1995 May-Jun;15(3):201-6. doi: 10.1002/jat.2550150310. J Appl Toxicol. 1995. PMID: 7560740
-
Chelation therapy in intoxications with mercury, lead and copper.J Trace Elem Med Biol. 2015;31:188-92. doi: 10.1016/j.jtemb.2014.04.010. Epub 2014 May 14. J Trace Elem Med Biol. 2015. PMID: 24894443 Review.
-
Succimer, an oral lead chelator.Clin Pharm. 1991 Dec;10(12):914-22. Clin Pharm. 1991. PMID: 1663439 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical